NO996137D0 - Preparater for behandling og forebygging av arteriell trombose og anvendelse av en faktor Xa inhibitor alene og/eller kombinert med et blodplate-antiaggregeringsmiddel - Google Patents

Preparater for behandling og forebygging av arteriell trombose og anvendelse av en faktor Xa inhibitor alene og/eller kombinert med et blodplate-antiaggregeringsmiddel

Info

Publication number
NO996137D0
NO996137D0 NO996137A NO996137A NO996137D0 NO 996137 D0 NO996137 D0 NO 996137D0 NO 996137 A NO996137 A NO 996137A NO 996137 A NO996137 A NO 996137A NO 996137 D0 NO996137 D0 NO 996137D0
Authority
NO
Norway
Prior art keywords
preparations
prevention
factor
treatment
combination
Prior art date
Application number
NO996137A
Other languages
English (en)
Other versions
NO323739B1 (no
NO996137L (no
Inventor
Andre Bernat
Jean-Marc Herbert
Maurice Petitou
Ronald Van Amsterdam
Original Assignee
Sanofi Synthelabo
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo, Akzo Nobel Nv filed Critical Sanofi Synthelabo
Publication of NO996137D0 publication Critical patent/NO996137D0/no
Publication of NO996137L publication Critical patent/NO996137L/no
Publication of NO323739B1 publication Critical patent/NO323739B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19996137A 1997-06-13 1999-12-10 Preparater for behandling og forebygging av arteriell trombose og anvendelse av en faktor Xa inhibitor kombinert med et antiblodplateaggregeringsmiddel NO323739B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9707368A FR2764511B1 (fr) 1997-06-13 1997-06-13 Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
PCT/FR1998/001172 WO1998056365A1 (fr) 1997-06-13 1998-06-09 INHIBITEUR DU FACTEUR Xa SEUL OU EN COMBINAISON AVEC UN ANTIAGREGANT PLAQUETTAIRE, CONTRE LA THROMBOSE ARTERIELLE

Publications (3)

Publication Number Publication Date
NO996137D0 true NO996137D0 (no) 1999-12-10
NO996137L NO996137L (no) 2000-02-14
NO323739B1 NO323739B1 (no) 2007-07-02

Family

ID=9507960

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19996137A NO323739B1 (no) 1997-06-13 1999-12-10 Preparater for behandling og forebygging av arteriell trombose og anvendelse av en faktor Xa inhibitor kombinert med et antiblodplateaggregeringsmiddel

Country Status (43)

Country Link
US (2) US6541488B1 (no)
EP (1) EP0986376B1 (no)
JP (1) JP3988803B2 (no)
KR (1) KR100598451B1 (no)
CN (1) CN1253150C (no)
AR (1) AR012247A1 (no)
AT (1) ATE384528T1 (no)
AU (1) AU728826B2 (no)
BR (1) BR9810520A (no)
CA (1) CA2293415C (no)
CO (1) CO4940476A1 (no)
CY (1) CY1107912T1 (no)
CZ (1) CZ299518B6 (no)
DE (1) DE69839046T2 (no)
DK (1) DK0986376T3 (no)
DZ (1) DZ2512A1 (no)
EE (1) EE04737B1 (no)
ES (1) ES2299209T3 (no)
FR (1) FR2764511B1 (no)
GT (1) GT199800171A (no)
HK (1) HK1032750A1 (no)
HR (1) HRP980322B1 (no)
HU (1) HU227956B1 (no)
ID (1) ID29309A (no)
IL (1) IL133452A (no)
IS (1) IS2619B (no)
ME (1) ME00685B (no)
MY (1) MY124648A (no)
NO (1) NO323739B1 (no)
NZ (1) NZ501452A (no)
PL (1) PL193405B1 (no)
PT (1) PT986376E (no)
RS (1) RS49902B (no)
RU (1) RU2212886C2 (no)
SA (1) SA98190552B1 (no)
SI (1) SI0986376T1 (no)
SK (1) SK286311B6 (no)
TR (1) TR199903087T2 (no)
TW (1) TW565442B (no)
UA (1) UA70919C2 (no)
UY (1) UY25044A1 (no)
WO (1) WO1998056365A1 (no)
ZA (1) ZA985137B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire
EP1156803A4 (en) 1999-02-09 2004-03-17 Bristol Myers Squibb Co FXA LACTAM INHIBITORS AND METHOD
US6344450B1 (en) 1999-02-09 2002-02-05 Bristol-Myers Squibb Company Lactam compounds and their use as inhibitors of serine proteases and method
FR2793687B1 (fr) * 1999-04-26 2001-08-24 Sanofi Sa Nouvelle composition injectable d'un anticoagulant
FR2800074B1 (fr) * 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
DE60217835D1 (en) 2001-02-28 2007-03-15 John H Griffin Plasmaglucosylceramiddefizienz als risikofaktor für thrombose und modulator von anticoagulant protein c
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs
WO2004031143A2 (en) 2002-10-02 2004-04-15 Bristol-Myers Squibb Company Novel combination of a factor xa inhibitor and clopidogrel
WO2004048363A1 (ja) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
EP1679067A4 (en) * 2003-09-19 2010-04-07 Kissei Pharmaceutical COMBINED MEDICINES
WO2005087266A1 (en) * 2004-03-05 2005-09-22 Vddi Pharmaceuticals Combination therapy for inhibition of platelet aggregation
CN1914915A (zh) * 2004-04-23 2007-02-14 住友电气工业株式会社 活动图像数据的编码方法、解码方法及实施这些方法的终端装置、以及双向对话型系统
TWI396686B (zh) 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
US7563780B1 (en) * 2004-06-18 2009-07-21 Advanced Cardiovascular Systems, Inc. Heparin prodrugs and drug delivery stents formed therefrom
JP5557410B2 (ja) * 2004-07-13 2014-07-23 第一三共株式会社 経口投与による血栓・塞栓の予防治療剤
US20070105825A1 (en) * 2004-09-16 2007-05-10 Yuji Hoyano Concurrent drugs
AU2006301240A1 (en) * 2005-10-10 2007-04-19 Msd Oss B.V. Antithrombotic compound
CA2735983A1 (en) * 2008-09-10 2010-03-18 Transpharma Medical Ltd. Transdermal delivery of oligosaccharides
WO2011149110A1 (en) 2010-05-28 2011-12-01 Daiichi Sankyo Company, Limited Novel composition for the prevention and/or treatment of thromboembolism
CA2966249C (en) * 2014-10-30 2019-06-18 Chengdu Baiyu Pharmaceutical Co., Ltd. Pharmaceutical composition containing ginkgolide b and xa factor inhibitor, preparation method thereof and use thereof
CN106860868B (zh) * 2015-12-11 2019-11-22 北京百奥药业有限责任公司 沙班类药物与蚓激酶的药物组合物、制剂及其应用
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2548189B1 (fr) * 1983-07-01 1986-04-11 Choay Sa Nouveaux produits contenant des oligosaccharides, leur preparation et leurs applications biologiques et biochimiques
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
FR2728901B1 (fr) * 1994-12-28 1997-03-28 Sanofi Sa Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
DK0946185T4 (da) 1996-11-27 2010-08-30 Aventis Pharma Inc Farmaceutisk præparat, som omfatter en forbindelse med anti-Xa-aktivitet og en blodpladeaggregations antagonistforbindelse
FR2764511B1 (fr) * 1997-06-13 2000-09-08 Sanofi Sa Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire

Also Published As

Publication number Publication date
RU2212886C2 (ru) 2003-09-27
PL193405B1 (pl) 2007-02-28
EP0986376B1 (fr) 2008-01-23
NZ501452A (en) 2002-06-28
YU63699A (sh) 2002-06-19
US6541488B1 (en) 2003-04-01
SK286311B6 (en) 2008-07-07
BR9810520A (pt) 2000-09-19
HUP0002175A3 (en) 2003-05-28
WO1998056365A1 (fr) 1998-12-17
KR20010013690A (ko) 2001-02-26
HU227956B1 (en) 2012-07-30
RS49902B (sr) 2008-08-07
DE69839046D1 (de) 2008-03-13
ME00685B (me) 2008-08-07
DE69839046T2 (de) 2009-01-15
EP0986376A1 (fr) 2000-03-22
CZ446099A3 (cs) 2000-04-12
NO323739B1 (no) 2007-07-02
GT199800171A (es) 2000-04-21
SA98190552B1 (ar) 2006-09-09
CY1107912T1 (el) 2013-09-04
AR012247A1 (es) 2000-09-27
IL133452A0 (en) 2001-04-30
HK1032750A1 (en) 2001-08-03
FR2764511B1 (fr) 2000-09-08
ZA985137B (en) 1999-01-07
CO4940476A1 (es) 2000-07-24
NO996137L (no) 2000-02-14
UY25044A1 (es) 2000-10-31
HRP980322B1 (en) 2003-12-31
HUP0002175A1 (hu) 2000-11-28
HRP980322A2 (en) 1999-04-30
ATE384528T1 (de) 2008-02-15
US20040092477A1 (en) 2004-05-13
MY124648A (en) 2006-06-30
CA2293415A1 (en) 1998-12-17
EE9900574A (et) 2000-08-15
IS2619B (is) 2010-05-15
IL133452A (en) 2004-09-27
IS5280A (is) 1999-11-30
TW565442B (en) 2003-12-11
CN1253150C (zh) 2006-04-26
TR199903087T2 (xx) 2000-05-22
JP2002504110A (ja) 2002-02-05
CN1274281A (zh) 2000-11-22
PL337288A1 (en) 2000-08-14
UA70919C2 (uk) 2004-11-15
AU728826B2 (en) 2001-01-18
DK0986376T3 (da) 2008-05-13
JP3988803B2 (ja) 2007-10-10
DZ2512A1 (fr) 2003-02-01
SK170999A3 (en) 2000-07-11
AU7924698A (en) 1998-12-30
KR100598451B1 (ko) 2006-07-10
CA2293415C (en) 2011-08-09
CZ299518B6 (cs) 2008-08-20
ES2299209T3 (es) 2008-05-16
PT986376E (pt) 2008-04-01
SI0986376T1 (sl) 2008-06-30
FR2764511A1 (fr) 1998-12-18
ID29309A (id) 2001-08-16
EE04737B1 (et) 2006-12-15

Similar Documents

Publication Publication Date Title
NO996137D0 (no) Preparater for behandling og forebygging av arteriell trombose og anvendelse av en faktor Xa inhibitor alene og/eller kombinert med et blodplate-antiaggregeringsmiddel
FI950587A0 (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
FI970214A0 (fi) Droloksifeenin käyttö sydänverisuonitautien hoitamiseksi
DE69502489D1 (de) Haftkleber und artikel
FI970357A (fi) Tyypin II diabeteksen hoitoon käyttökelpoisia bensoksatsoli- ja pyridiinijohdannaisia
NO20021784L (no) Anvendelse av dipyridamol eller mopidamol for fremstilling av et medikament for behandling og forebygging av fibrin-avhengigmikrosirkulasjonsforstyrrelser
NZ332757A (en) Substituted tetrahydroisoquinoline benzamide derivatives and their use as anticonvulsants and psycho-active agents
FI955786A (fi) Luonnontuotteiden ja vastaavien yhdisteiden käyttö sydän- ja verisuonisairauksien hoitoon
PL320922A1 (en) Application of mhc-ii bonding and/or somulating molecules in prevention and/or treatment of diseases involving inflammatory processes
NO931400D0 (no) Derivater av adipogeneseinhiberende faktor, samt fremstilling og anvendelse derav
DE59504748D1 (de) Polymerisierbare oligo- und/oder polyalkensäuren
IL110303A0 (en) Use of nabumetone or 6mna in the manufacture of medicaments
NO954175D0 (no) Anvendelse av vWF-inneholdende konsentrater som kombinasjonsterapi ved antitrombotika og fibrinolytika terapi
IL131085A0 (en) The use of levobupivacaine or ropivacaine in treating migraine
ATE122206T1 (de) Verminderung und inhibition des gehalts von äthylenthioharnstoff in alkylenbisdithiocarbamaten.
EP0453658A3 (en) Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases
NO962503D0 (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
NO942686D0 (no) Anvendelse av 3-arylindol- og 3-arylindazolderivater ved behandling av psykoser
ITMI922379A1 (it) Articoli fotocromatici e procedimento per la loro preparazione
LV11105A (lv) Arstniecibas lidzeklis ar pretinfekciju iedarbibu un ta pielietojums infekcijas slimibu arstesanai
KR950024227U (ko) 감 꼭지 및 껍질 제거기
IL130103A0 (en) The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis
IL111571A0 (en) Set of elements for use in constructing shelves and the like
LV10916A (lv) Metoklopramida lietosana kardalgijas arstesana
GB9700667D0 (en) Materials and methods relating to the treatment of biofilms

Legal Events

Date Code Title Description
MK1K Patent expired